Roivant Sciences Ltd (NAS:ROIVW)
$ 2.75 -0.11 (-3.85%) Market Cap: - Enterprise Value: - PE Ratio: 2.13 PB Ratio: 1.61 GF Score: 60/100

Roivant Sciences Ltd to Announce Positive Results From the Induction Period of the TUSCANY-2 Call Transcript

Jan 04, 2023 / 01:00PM GMT
Operator

Good day, and thank you for standing by. Welcome to the Roivant Sciences Investor Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Stephanie Lee. Please go ahead.

Stephanie Lee
Roivant Sciences Ltd. - Media

Good morning, and thank you for joining today's call to discuss RVT-3101 Phase 2b data. I'm Stephanie Lee with Roivant. Presenting today, we've got Matt Gline, Chief Executive Officer of Roivant; and Mayukh Sukhatme, President and Chief Investment Officer of Roivant.

For those dialing in via conference call, you can find the slides being presented today as well as the press release announcing these updates on our IR website at www.investors.roivant.com. We'll also be providing the current slide numbers as we present to help you follow along.

I'd like to remind you that we'll be making certain forward-looking statements today during today's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot